APOC3 and pulmonary fibrosis: There was suggestive evidence for an association between genetically predicted APOC3 inhibition and idiopathic pulmonary fibrosis (OR = 1.56, 95% CI=1.17 to 2.08, P=2.5e-03), although not passing the multiple testing threshold.